1. Home
  2. TLYS vs NXTC Comparison

TLYS vs NXTC Comparison

Compare TLYS & NXTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tilly's Inc.

TLYS

Tilly's Inc.

HOLD

Current Price

$5.05

Market Cap

43.3M

ML Signal

HOLD

Logo NextCure Inc.

NXTC

NextCure Inc.

HOLD

Current Price

$11.00

Market Cap

35.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TLYS
NXTC
Founded
1982
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
43.3M
35.9M
IPO Year
2011
2019

Fundamental Metrics

Financial Performance
Metric
TLYS
NXTC
Price
$5.05
$11.00
Analyst Decision
Hold
Strong Buy
Analyst Count
1
3
Target Price
$2.00
$23.00
AVG Volume (30 Days)
2.2M
29.8K
Earning Date
03-11-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
62.34
N/A
EPS
N/A
N/A
Revenue
N/A
$22,378,000.00
Revenue This Year
$4.66
N/A
Revenue Next Year
$1.74
N/A
P/E Ratio
$17.28
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.57
$0.29
52 Week High
$5.22
$15.74

Technical Indicators

Market Signals
Indicator
TLYS
NXTC
Relative Strength Index (RSI) 90.15 51.00
Support Level $1.38 $10.73
Resistance Level N/A $14.01
Average True Range (ATR) 0.37 1.06
MACD 0.04 0.16
Stochastic Oscillator 90.03 76.12

Price Performance

Historical Comparison
TLYS
NXTC

About TLYS Tilly's Inc.

Tilly's Inc works as a specialty retailer of casual apparel, footwear, and accessories for young men, young women, boys, and girls. It offers an unparalleled selection of relevant brands, styles, colors, sizes, and price points. It delivers branded fashion, and core styles for tops, outerwear, bottoms, and dresses. It also provides backpacks, hats, sunglasses, headphones, handbags, watches, and jewelry. It markets its products under the brand names of Vans, RVCA, Adidas, Nike SB, and Hurley among others. It operates its stores in malls, lifestyle centers, power centers, community centers, outlet centers, street-front locations, and also through e-commerce.

About NXTC NextCure Inc.

NextCure Inc is a clinical-stage biopharmaceutical company that is focused on advancing inventive medicines that treat cancer patients that do not respond to, or that have disease progression on, current therapies, through the use of targeted therapies including antibody-drug conjugates. The company's product candidates include NC410 a fusion protein of LAIR-2, a fusion protein that, in combination with pembrolizumab, demonstrated early evidence of clinical activity in colorectal (CRC) and ovarian cancers, and LNCB74, an ADC that is directed to B7-H4, a clinically validated cancer target. The company is also seeking a partner for its other clinical programs such as NC525 and NC318 and its preclinical non-oncology programs NC605, for chronic bone diseases and NC181, for Alzheimer's disease.

Share on Social Networks: